FDA Reorg Makes Chief Of Staff Liaison Between Centers And Commissioner
This article was originally published in The Gray Sheet
Executive Summary
A newly created FDA Office of the Chief of Staff will serve as the major point of contact between FDA centers and the Commissioner, according to a restructuring announced Aug. 30